RESPONSE OF GLYCEMIC CONTROL TO LOW LEVEL LASER THERAPY IN TYPE 2 DIABETIC PATIENTS.
- Conditions
- Nutritional, Metabolic, Endocrine
- Registration Number
- PACTR202004826694476
- Brief Summary
aser group shows more improvements than control group in fasting blood glucose level and poatprandial blood glucose level which decreased and more improves in fasting C peptide in laser group and it also can enhance acute lowering response of blood glucose level by 22.7 mg/dl
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
•Type II Diabetes mellitus, started more than one year ago.
• Both genders.
•BMI from 25 kg/m2 to 39.9Kg/m2.
•They receive medical therapy for diabetes one year or more ago.
•Being clinically stable.
•Glycated hemoglobin = 6.5 %.
•Fasting blood glucose level > 126 mg/dl.
•Two hour Postprandial blood glucose level = 200 mg/dl.
.
•Patients with unstable glycemic control.
•History of uncontrolled cardiovascular complications.
•History of malignancy or hemorrhagic diseases.
•Patients with a cardiac pacemaker or pregnant women.
•Complete destruction of beta cell, (estimated from HOMA test (%B)).
•Participants diagnosed with pre-diabetes, gestational diabetes, or type1 diabetes.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method -Measuring glycated hemoglobin (HbA1c): was recommended as an essential indicator for the monitoring of blood glucose control. The blood HbA1c = 6.5% was considered as diabetes; -Measuring fasting plasma Glucose level (FPG): There was eight hours fasting before test; <br>-Measuring postprandial plasma Glucose level (PPPG): Two hour after eating from FPG test;<br>-Measuring Fasting C peptide level: to detect level of: - acute effect of laser on glycemic control post sessions
- Secondary Outcome Measures
Name Time Method Beta cell function (%B).<br>• Insulin sensitivity (%S).<br>• Insulin resistance (%IR). <br>by using HOMA-IR calculator after measuring fasting blood glucose level, fasting C peptide.<br>